...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Is it just coincidental......

that both Abbvie and Resverlogix are listed as presenting on Tuesday October 17th at 9:30 AM in Elizabethan C in the draft version of the BIO Investor Schedule (draft version 10/11)? Or that Abbvie is also a company with a BET bromodomain inhibitor in clinical trials?

Go to the conference homepage and scroll down near bottom and click on "Download Presenting Company Data". Could be nothing but a scheduling mistake on the end of the BIO Investor coordinators and they'll change one of 'em to a different day/time/room slot. Otherwise they share a stage? Or first come first serve? LOL.

BearDownAZ

Share
New Message
Please login to post a reply